{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:07:16Z","timestamp":1777392436761,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2020R1A4A3078645"],"award-info":[{"award-number":["2020R1A4A3078645"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1C1C1014606"],"award-info":[{"award-number":["2021R1C1C1014606"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00253-022-12218-0","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T09:03:07Z","timestamp":1665651787000},"page":"7531-7545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19\u03b1 protein"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8144-6108","authenticated-orcid":false,"given":"Haein","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geunhwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-2757","authenticated-orcid":false,"given":"Seulha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boram","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-9842","authenticated-orcid":false,"given":"Jinmyoung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1498-5624","authenticated-orcid":false,"given":"Hee Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-0657","authenticated-orcid":false,"given":"Tai Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"12218_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.enzmictec.2014.05.004","volume":"63","author":"K-Y Ahn","year":"2014","unstructured":"Ahn K-Y, Lee B, Han K-Y, Song J-A, Lee DS, Lee J (2014) Synthesis of Mycoplasma arginine deiminase in E. coli using stress-responsive proteins. Enzyme Microb Technol 63:46\u201349","journal-title":"Enzyme Microb Technol"},{"issue":"39","key":"12218_CR2","doi-asserted-by":"publisher","first-page":"14147","DOI":"10.1073\/pnas.1404171111","volume":"111","author":"CA Changou","year":"2014","unstructured":"Changou CA, Chen Y-R, Xing L, Yen Y, Chuang FY, Cheng RH, Bold RJ, Ann DK, Kung H-J (2014) Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci USA 111(39):14147\u201314152","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"12218_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/bit.20550","volume":"91","author":"SS Choi","year":"2005","unstructured":"Choi SS, Rhee WJ, Park TH (2005) Beneficial effect of silkworm hemolymph on a CHO cell system: inhibition of apoptosis and increase of EPO production. Biotechnol Bioeng 91(7):793\u2013800","journal-title":"Biotechnol Bioeng"},{"issue":"12","key":"12218_CR4","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/ijc.25202","volume":"126","author":"B Delage","year":"2010","unstructured":"Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, Szlosarek PW (2010) Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126(12):2762\u20132772","journal-title":"Int J Cancer"},{"issue":"7","key":"12218_CR5","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1007\/s00253-020-10432-2","volume":"104","author":"R Dhankhar","year":"2020","unstructured":"Dhankhar R, Gupta V, Kumar S, Kapoor RK, Gulati P (2020) Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment. Appl Microbiol Biotechnol 104(7):2857\u20132869","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"12218_CR6","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/cncr.20057","volume":"100","author":"BJ Dillon","year":"2004","unstructured":"Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100(4):826\u2013833","journal-title":"Cancer"},{"issue":"3","key":"12218_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12257-017-0060-0","volume":"22","author":"BH Do","year":"2017","unstructured":"Do BH, Park S, Kwon GG, Nguyen MT, Kang HJ, Song J-A, Yoo J, Nguyen AN, Jang J, Jang M (2017) Soluble expression and purification of bioactive interleukin 33 in E coli. Biotechnol Bioprocess Eng 22(3):256\u2013264","journal-title":"Biotechnol Bioprocess Eng"},{"key":"12218_CR8","doi-asserted-by":"publisher","first-page":"109432","DOI":"10.1016\/j.enzmictec.2019.109432","volume":"131","author":"AS El-Sayed","year":"2019","unstructured":"El-Sayed AS, Shindia AA, Abou Zeid AA, Yassin AM, Sitohy MZ, Sitohy B (2019) Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity. Enzyme Microb Technol 131:109432","journal-title":"Enzyme Microb Technol"},{"issue":"19","key":"12218_CR9","first-page":"5443","volume":"62","author":"CM Ensor","year":"2002","unstructured":"Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA (2002) Pegylated arginine deiminase (ADI-SS-PEG 20,000 MW) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res 62(19):5443\u20135450","journal-title":"Cancer Res"},{"issue":"4","key":"12218_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jbiotec.2013.06.025","volume":"167","author":"LR Fayura","year":"2013","unstructured":"Fayura LR, Boretsky YR, Pynyaha YV, Wheatley DN, Sibirny AA (2013) Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli. J Biotech 167(4):420\u2013426","journal-title":"J Biotech"},{"key":"12218_CR11","doi-asserted-by":"crossref","unstructured":"Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server.\u00a0In: Walker JM (ed) The proteomics protocols handbook. Springer, pp 571\u2013607","DOI":"10.1385\/1-59259-890-0:571"},{"issue":"9","key":"12218_CR12","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1158\/1078-0432.CCR-18-3729","volume":"25","author":"PE Hall","year":"2019","unstructured":"Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA (2019) A phase I study of pegylated arginine deiminase (Pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma arginine deprivation therapy in recurrent high-grade gliomas. Clin Cancer Res 25(9):2708\u20132716","journal-title":"Clin Cancer Res"},{"issue":"3","key":"12218_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","volume":"9","author":"Z Hussain","year":"2019","unstructured":"Hussain Z, Khan S, Imran M, Sohail M, Shah SWA, de Matas M (2019) PEGylation: A promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. Drug Deliv Transl Res 9(3):721\u2013734","journal-title":"Drug Deliv Transl Res"},{"issue":"9","key":"12218_CR14","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","volume":"270","author":"A Husson","year":"2003","unstructured":"Husson A, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne A (2003) Argininosuccinate synthetase from the urea cycle to the citrulline\u2013NO cycle. Eur J Biochem 270(9):1887\u20131899","journal-title":"Eur J Biochem"},{"issue":"16","key":"12218_CR15","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1158\/1078-0432.CCR-19-1905","volume":"26","author":"JX Ji","year":"2020","unstructured":"Ji JX, Cochrane DR, Tessier-Cloutier B, Chen SY, Ho G, Pathak KV, Alcazar IN, Farnell D, Leung S, Cheng A (2020) Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase\u2013deficient ovarian cancer, including small-cell carcinoma of the ovary, hypercalcemic type arginine depletion to treat rare ovarian cancers. Clin Cancer Res 26(16):4402\u20134413","journal-title":"Clin Cancer Res"},{"key":"12218_CR16","first-page":"2043","volume":"11","author":"PG Jobin","year":"1864","unstructured":"Jobin PG, Butler GS (1864) Overall CM (2017) New intracellular activities of matrix metalloproteinases shine in the moonlight. Biochim Biophys Acta - Mol 11:2043\u20132055","journal-title":"Biochim Biophys Acta - Mol"},{"key":"12218_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jbiotec.2014.11.025","volume":"194","author":"Y-S Kang","year":"2015","unstructured":"Kang Y-S, Song J-A, Han K-Y, Lee J (2015) Escherichia coli EDA is a novel fusion expression partner to improve solubility of aggregation-prone heterologous proteins. J Biotechnol 194:39\u201347","journal-title":"J Biotechnol"},{"key":"12218_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijbiomac.2021.12.015","volume":"196","author":"A Kawatra","year":"2021","unstructured":"Kawatra A, Dhankhar R, Gulati P (2021) Microbial arginine deiminase: a multifaceted green catalyst in biomedical sciences. Int J Biol Macromol 196:151\u2013162","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"12218_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF02940260","volume":"8","author":"EJ Kim","year":"2003","unstructured":"Kim EJ, Park TH (2003) Anti-apoptosis engineering. Biotechnol. Bioprocess Eng 8(2):76\u201382","journal-title":"Bioprocess Eng"},{"issue":"1","key":"12218_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/bp034130y","volume":"20","author":"EJ Kim","year":"2004","unstructured":"Kim EJ, Rhee WJ, Park TH (2004) Inhibition of apoptosis by a Bombyx mori gene. Biotechnol Prog 20(1):324\u2013329","journal-title":"Biotechnol Prog"},{"issue":"4","key":"12218_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF02931854","volume":"10","author":"JE Kim","year":"2005","unstructured":"Kim JE, Kim EJ, Rhee WJ, Park TH (2005) Enhanced production of recombinant protein in Escherichia coli using silkworm hemolymph. Biotechnol Bioprocess Eng 10(4):353","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"2","key":"12218_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","volume":"69","author":"RH Kim","year":"2009","unstructured":"Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung H-J (2009) Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 69(2):700\u2013708","journal-title":"Cancer Res"},{"issue":"1","key":"12218_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-022-00280-8","volume":"26","author":"SHL Kim","year":"2022","unstructured":"Kim SHL, Cho S, Kim S, Kwon J, Lee J, Koh RH, Park JH, Lee H, Park TH, Hwang NS (2022) Cellular direct conversion by cell penetrable OCT4-30Kc19 protein and BMP4 growth factor. Biomater Res 26(1):1\u201318","journal-title":"Biomater Res"},{"issue":"1","key":"12218_CR24","doi-asserted-by":"publisher","first-page":"2000176","DOI":"10.1002\/adbi.202000176","volume":"5","author":"H Lee","year":"2021","unstructured":"Lee H, An YH, Kim TK, Ryu J, Park GK, Park MJ, Ko J, Kim H, Choi HS, Hwang NS (2021) Enhancement of wound healing efficacy by increasing the stability and skin-penetrating property of bFGF using 30Kc19\u03b1-based fusion protein. Adv Biol 5(1):2000176","journal-title":"Adv Biol"},{"issue":"9","key":"12218_CR25","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1021\/acsbiomaterials.0c00827","volume":"6","author":"H Lee","year":"2020","unstructured":"Lee H, Kim SHL, Yoon H, Ryu J, Park HH, Hwang NS, Park TH (2020) Intracellular delivery of recombinant RUNX2 facilitated by cell-penetrating protein for the osteogenic differentiation of hMSCs. ACS Biomater Sci Eng 6(9):5202\u20135214","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"12218_CR26","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.biomaterials.2013.11.001","volume":"35","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Park HH, Kim JA, Park JH, Ryu J, Choi J, Lee J, Rhee WJ, Park TH (2014) Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles. Biomater 35(5):1696\u20131704","journal-title":"Biomater"},{"issue":"3","key":"12218_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0165-6147(00)01447-4","volume":"21","author":"M Lindgren","year":"2000","unstructured":"Lindgren M, H\u00e4llbrink M, Prochiantz A, Langel \u00dc (2000) Cell-penetrating peptides. Trends Pharmacol Sci 21(3):99\u2013103","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"12218_CR28","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1158\/1535-7163.MCT-13-0302","volume":"12","author":"Y Long","year":"2013","unstructured":"Long Y, Tsai W-B, Wangpaichitr M, Tsukamoto T, Savaraj N, Feun LG, Kuo MT (2013) Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction. Mol Cancer Ther 12(11):2581\u20132590","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"12218_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.coph.2006.04.004","volume":"6","author":"M M\u00e4e","year":"2006","unstructured":"M\u00e4e M, Langel \u00dc (2006) Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol 6(5):509\u2013514","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"12218_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajps.2015.08.011","volume":"11","author":"P Mishra","year":"2016","unstructured":"Mishra P, Nayak B, Dey R (2016) PEGylation in anti-cancer therapy: an overview. Asian J Pharm Sci 11(3):337\u2013348","journal-title":"Asian J Pharm Sci"},{"issue":"15","key":"12218_CR31","first-page":"4522","volume":"50","author":"K Miyazaki","year":"1990","unstructured":"Miyazaki K, Takaku H, Umeda M, Fujita T, Huang W, Kimura T, Yamashita J, Horio T (1990) Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 50(15):4522\u20134527","journal-title":"Cancer Res"},{"issue":"1","key":"12218_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2007.11.038","volume":"261","author":"Y Ni","year":"2008","unstructured":"Ni Y, Schwaneberg U, Sun Z-H (2008) Arginine deiminase, a potential anti-tumor drug. Cancer Lett 261(1):1\u201311","journal-title":"Cancer Lett"},{"key":"12218_CR33","doi-asserted-by":"crossref","unstructured":"Oginsky EL (1957) Isolation and determination of arginine and citrulline.\u00a0Methods Enzymol 3:639\u2013643","DOI":"10.1016\/S0076-6879(57)03434-5"},{"key":"12218_CR34","first-page":"40","volume":"12","author":"K Oh-Hashi","year":"2017","unstructured":"Oh-Hashi K, Furuta E, Fujimura K, Hirata Y (2017) Application of a novel HiBiT peptide tag for monitoring ATF4 protein expression in Neuro2a cells. Biochem Biophys Rep 12:40\u201345","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"12218_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13770-022-00430-y","volume":"19","author":"NM Phan","year":"2022","unstructured":"Phan NM, Nguyen TL, Kim J (2022) Nanozyme-based enhanced cancer immunotherapy. Tissue Eng Regen Med 19(2):237\u2013252","journal-title":"Tissue Eng Regen Med"},{"key":"12218_CR36","unstructured":"Park G (2022) Enhancement of solubility, cell penetration, and stability of arginine deiminase using 30Kc19\u03b1 for effective melanoma treatment. Dissertation, Seoul National University"},{"issue":"12","key":"12218_CR37","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/biot.201400253","volume":"9","author":"HH Park","year":"2014","unstructured":"Park HH, Sohn Y, Yeo JW, Park JH, Lee HJ, Ryu J, Rhee WJ, Park TH (2014a) Dimerization of 30Kc19 protein in the presence of amphiphilic moiety and importance of Cys-57 during cell penetration. Biotechnol J 9(12):1582\u20131593","journal-title":"Biotechnol J"},{"issue":"9","key":"12218_CR38","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.procbio.2014.05.008","volume":"49","author":"HH Park","year":"2014","unstructured":"Park HH, Sohn Y, Yeo JW, Park JH, Lee HJ, Ryu J, Rhee WJ, Park TH (2014b) Identification and characterization of a novel cell-penetrating peptide of 30Kc19 protein derived from Bombyx mori. Process Biochem 49(9):1516\u20131526","journal-title":"Process Biochem"},{"key":"12218_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.procbio.2017.08.021","volume":"63","author":"HH Park","year":"2017","unstructured":"Park HH, Woo YH, Ryu J, Lee HJ, Park JH, Park TH (2017) Enzyme delivery using protein-stabilizing and cell-penetrating 30Kc19\u03b1 protein nanoparticles. Process Biochem 63:76\u201383","journal-title":"Process Biochem"},{"issue":"35","key":"12218_CR40","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1016\/j.biomaterials.2012.08.063","volume":"33","author":"JH Park","year":"2012","unstructured":"Park JH, Lee JH, Park HH, Rhee WJ, Choi SS, Park TH (2012a) A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm. Biomater 33(35):9127\u20139134","journal-title":"Biomater"},{"issue":"1","key":"12218_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.procbio.2011.10.022","volume":"47","author":"JH Park","year":"2012","unstructured":"Park JH, Park HH, Choi SS, Park TH (2012b) Stabilization of enzymes by the recombinant 30Kc19 protein. Process Biochem 47(1):164\u2013169","journal-title":"Process Biochem"},{"issue":"38","key":"12218_CR42","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1038\/onc.2016.37","volume":"35","author":"M Patil","year":"2016","unstructured":"Patil M, Bhaumik J, Babykutty S, Banerjee U, Fukumura D (2016) Arginine dependence of tumor cells: targeting a chink in cancer\u2019s armor. Oncogene 35(38):4957\u20134972","journal-title":"Oncogene"},{"issue":"4","key":"12218_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10585-005-8672-8","volume":"22","author":"AMM Pereira","year":"2005","unstructured":"Pereira AMM, Strasberg-Rieber M, Rieber M (2005) Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment. Clin Exp Metastasis 22(4):285\u2013295","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"12218_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4143\/crt.2013.45.4.251","volume":"45","author":"MM Phillips","year":"2013","unstructured":"Phillips MM, Sheaff MT, Szlosarek PW (2013) Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges. Cancer Res Treat 45(4):251","journal-title":"Cancer Res Treat"},{"issue":"5","key":"12218_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2230.2005.01849.x","volume":"30","author":"P Redondo","year":"2005","unstructured":"Redondo P, Lloret P, Idoate M, Inoges S (2005) Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Clin Exp Dermatol 30(5):541\u2013545","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"12218_CR46","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1021\/bp990093s","volume":"15","author":"WJ Rhee","year":"1999","unstructured":"Rhee WJ, Kim EJ, Park TH (1999) Kinetic effect of silkworm hemolymph on the delayed host cell death in an insect cell-baculovirus system. Biotechnol Prog 15(6):1028\u20131032","journal-title":"Biotechnol Prog"},{"issue":"5","key":"12218_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s12257-009-0081-4","volume":"14","author":"WJ Rhee","year":"2009","unstructured":"Rhee WJ, Lee EH, Park TH (2009) Expression of Bombyx mori 30Kc19 protein in Escherichia coli and its anti-apoptotic effect in Sf9 cell. Biotechnol Bioprocess Eng 14(5):645","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"2","key":"12218_CR48","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1159\/000495382","volume":"51","author":"C Riess","year":"2018","unstructured":"Riess C, Shokraie F, Classen CF, Kreikemeyer B, Fiedler T, Junghanss C, Maletzki C (2018) Arginine-depleting enzymes\u2013an increasingly recognized treatment strategy for therapy-refractory malignancies. Cell Physiol Biochem 51(2):854\u2013870","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"12218_CR49","first-page":"1323","volume":"21","author":"M Roomi","year":"2009","unstructured":"Roomi M, Monterrey J, Kalinovsky T, Rath M, Niedzwiecki A (2009) Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncol Rep 21(5):1323\u20131333","journal-title":"Oncol Rep"},{"key":"12218_CR50","doi-asserted-by":"publisher","first-page":"105717","DOI":"10.1016\/j.biocel.2020.105717","volume":"121","author":"J Ryu","year":"2020","unstructured":"Ryu J, Hwang NS, Park HH, Park TH (2020) Protein-based direct reprogramming of fibroblasts to neuronal cells using 30Kc19 protein and transcription factor Ascl1. Int J Biochem Cell Biol 121:105717","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"12218_CR51","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/biot.201600040","volume":"11","author":"J Ryu","year":"2016","unstructured":"Ryu J, Kim H, Park HH, Lee HJ, Park JH, Rhee WJ, Park TH (2016a) Protein-stabilizing and cell-penetrating properties of \u03b1-helix domain of 30Kc19 protein. Biotechnol J 11(11):1443\u20131451","journal-title":"Biotechnol J"},{"issue":"8","key":"12218_CR52","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1007\/s00253-015-7199-4","volume":"100","author":"J Ryu","year":"2016","unstructured":"Ryu J, Park HH, Park JH, Lee HJ, Rhee WJ, Park TH (2016b) Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein. Appl Microbiol Biotechnol 100(8):3523\u20133532","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"12218_CR53","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/bit.27362","volume":"117","author":"M Schneier","year":"2020","unstructured":"Schneier M, Razdan S, Miller AM, Briceno ME, Barua S (2020) Current technologies to endotoxin detection and removal for biopharmaceutical purification. Biotechnol Bioeng 117(8):2588\u20132609","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"12218_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99(4):303\u2013310","journal-title":"J Biosci Bioeng"},{"issue":"6","key":"12218_CR55","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1369\/0022155413484765","volume":"61","author":"AI Solli","year":"2013","unstructured":"Solli AI, Fadnes B, Winberg J-O, Uhlin-Hansen L, Hadler-Olsen E (2013) Tissue-and cell-specific co-localization of intracellular gelatinolytic activity and matrix metalloproteinase 2. J Histochem Cytochem 61(6):444\u2013461","journal-title":"J Histochem Cytochem"},{"key":"12218_CR56","doi-asserted-by":"publisher","first-page":"911614","DOI":"10.3389\/fbioe.2022.911614","volume":"10","author":"B Son","year":"2022","unstructured":"Son B, Yoon H, Ryu J, Lee H, Joo J, Park HH, Park TH (2022) Enhanced efficiency of generating human-induced pluripotent stem cells using Lin28-30Kc19 fusion protein. Front Bioeng Biotechnol 10:911614","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"12218_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.enzmictec.2011.04.013","volume":"49","author":"J-A Song","year":"2011","unstructured":"Song J-A, Lee D-S, Park J-S, Han K-Y, Lee J (2011) A novel Escherichia coli solubility enhancer protein for fusion expression of aggregation-prone heterologous proteins. Enzyme Microb Technol 49(2):124\u2013130","journal-title":"Enzyme Microb Technol"},{"key":"12218_CR58","doi-asserted-by":"publisher","first-page":"935553","DOI":"10.3389\/fphar.2022.935553","volume":"13","author":"N Sun","year":"2022","unstructured":"Sun N, Zhao X (2022) Argininosuccinate synthase 1, arginine deprivation therapy and cancer management. Front Pharmacol 13:935553","journal-title":"Front Pharmacol"},{"issue":"12","key":"12218_CR59","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/1535-7163.MCT-09-0794","volume":"8","author":"W-B Tsai","year":"2009","unstructured":"Tsai W-B, Aiba I, Lee S-y, Feun L, Savaraj N, Kuo MT (2009) Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc\/HIF-1\u03b1\/Sp4. Mol Cancer Ther 8(12):3223\u20133233","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"12218_CR60","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1021\/mp5001372","volume":"11","author":"F-LL Wu","year":"2014","unstructured":"Wu F-LL, Yeh T-H, Chen Y-L, Chiu Y-C, Cheng J-C, Wei M-F, Shen L-J (2014) Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Mol Pharm 11(8):2777\u20132786","journal-title":"Mol Pharm"},{"issue":"1","key":"12218_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jsb.2011.04.003","volume":"175","author":"J-P Yang","year":"2011","unstructured":"Yang J-P, Ma X-X, He Y-X, Li W-F, Kang Y, Bao R, Chen Y, Zhou C-Z (2011) Crystal structure of the 30 K protein from the silkworm Bombyx mori reveals a new member of the \u03b2-trefoil superfamily. J Struct Biol 175(1):97\u2013103","journal-title":"J Struct Biol"},{"issue":"8","key":"12218_CR62","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","volume":"39","author":"Q Yao","year":"2018","unstructured":"Yao Q, Kou L, Tu Y, Zhu L (2018) MMP-responsive \u2018smart\u2019 drug delivery and tumor targeting. Trends Pharmacol Sci 39(8):766\u2013781","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"12218_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1021\/acs.molpharmaceut.5b00706","volume":"13","author":"T-H Yeh","year":"2016","unstructured":"Yeh T-H, Chen Y-R, Chen S-Y, Shen W-C, Ann DK, Zaro JL, Shen L-J (2016) Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Mol Pharm 13(1):262\u2013271","journal-title":"Mol Pharm"},{"issue":"1","key":"12218_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.biotechadv.2014.11.005","volume":"33","author":"K Yu","year":"2015","unstructured":"Yu K, Liu C, Kim B-G, Lee D-Y (2015) Synthetic fusion protein design and applications. Biotechnol Adv 33(1):155\u2013164","journal-title":"Biotechnol Adv"},{"issue":"3","key":"12218_CR65","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1248\/bpb.b13-00661","volume":"37","author":"F Zhang","year":"2014","unstructured":"Zhang F, Liu M-r, Wan H-t (2014) Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol Pharm Bull 37(3):335\u2013339","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"12218_CR66","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1055-7903(02)00277-4","volume":"25","author":"M Z\u00fa\u00f1iga","year":"2002","unstructured":"Z\u00fa\u00f1iga M, P\u00e9rez G, Gonz\u00e1lez-Candelas F (2002) Evolution of arginine deiminase (ADI) pathway genes. Mol Phylogenetics Evol 25(3):429\u2013444","journal-title":"Mol Phylogenetics Evol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-022-12218-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-022-12218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T21:08:50Z","timestamp":1701205730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-022-12218-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":66,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["12218"],"URL":"https:\/\/doi.org\/10.1007\/s00253-022-12218-0","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}